OTCMKTS:TRSSF - Terrascend Stock Price, News & Analysis

$5.28
+0.08 (+1.54 %)
(As of 08/18/2019 04:00 PM ET)
Today's Range
$4.95
Now: $5.28
$5.29
50-Day Range
$4.4239
MA: $4.94
$5.40
52-Week Range
$3.2870
Now: $5.28
$10.4404
Volume36,155 shs
Average Volume53,663 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
TerrAscend Corp., a biopharmaceutical and wellness company, engages in the cultivation, development, and sale of medical cannabis in Canada. The company offers its cannabis products under the Knüba Naturals brand. It also provides education and support programs to physicians and patients through health care professionals. The company was incorporated in 2017 and is based in Mississauga, Canada.

Industry, Sector and Symbol

Industry Drug Manufacturers - Specialty & Generic
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:TRSSF
CUSIPN/A
CIKN/A
Phone855-837-7295

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

EmployeesN/A
Next Earnings DateN/A
OptionableNot Optionable

Receive TRSSF News and Ratings via Email

Sign-up to receive the latest news and ratings for TRSSF and its competitors with MarketBeat's FREE daily newsletter.


Terrascend (OTCMKTS:TRSSF) Frequently Asked Questions

What is Terrascend's stock symbol?

Terrascend trades on the OTCMKTS under the ticker symbol "TRSSF."

Has Terrascend been receiving favorable news coverage?

Media coverage about TRSSF stock has been trending negative this week, InfoTrie Sentiment Analysis reports. The research firm scores the sentiment of press coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Terrascend earned a news sentiment score of -2.3 on InfoTrie's scale. They also assigned news coverage about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the company's share price in the next few days. View News Stories for Terrascend.

Who are some of Terrascend's key competitors?

What other stocks do shareholders of Terrascend own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Terrascend investors own include Aurora Cannabis (ACB), Canopy Growth (CGC), Aphria (APHA), KushCo (KSHB), Medmen Enterprises (MMNFF), Cronos Group (CRON), OrganiGram (OGI), Curaleaf (CURLF), CV Sciences (CVSI) and Charlotte's Web (CWBHF).

Who are Terrascend's key executives?

Terrascend's management team includes the folowing people:
  • Dr. Michael Nashat, Founder, CEO, COO & Director (Age 35)
  • Mr. Matthew J. Johnson, Pres
  • Mr. Adam Kozak, Chief Financial Officer
  • Mr. Alex Correia, VP of Corp. Affairs & Communications
  • Ms. Dawn Vanek-Mithra, Director of Marketing

How do I buy shares of Terrascend?

Shares of TRSSF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Terrascend's stock price today?

One share of TRSSF stock can currently be purchased for approximately $5.28.

What is Terrascend's official website?

The official website for Terrascend is http://www.terrascend.com/.

How can I contact Terrascend?

The company can be reached via phone at 855-837-7295.


MarketBeat Community Rating for Terrascend (OTCMKTS TRSSF)

Community Ranking:  4.1 out of 5 (star star star star)
Outperform Votes:  13 (Vote Outperform)
Underperform Votes:  3 (Vote Underperform)
Total Votes:  16
MarketBeat's community ratings are surveys of what our community members think about Terrascend and other stocks. Vote "Outperform" if you believe TRSSF will outperform the S&P 500 over the long term. Vote "Underperform" if you believe TRSSF will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 8/18/2019 by MarketBeat.com Staff

Featured Article: Bond

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel